Welcome to our dedicated page for Costas news (Ticker: CSSI), a resource for investors and traders seeking the latest updates and insights on Costas stock.
The CSSI news archive on Stock Titan covers the public communications of Costas, Inc., which did business as Standard Dental Labs Inc. in the dental lab and dental prosthetics sector. These news items document the company’s transition toward a focused dental laboratory business, its acquisition strategy, and its later rebranding and ticker symbol change to Standard Dental Labs Inc. with the symbol TUTH after an interim period under CSSID.
Readers can find press releases describing the company’s efforts to acquire and consolidate privately owned dental labs, particularly in Florida and the Orlando area. The news flow includes updates on acquisitions such as Prime Dental Lab, commentary on consolidation trends in the dental lab industry, and the company’s retirement succession program for baby boomer dental lab owners seeking an exit or transition.
Other articles highlight regulatory and capital markets developments. These include the filing of annual reports, work with auditors and regulators, efforts to restore FINRA compliance, the rescinding of a cease trade order in Canada, and the filing of a Tier 2 Regulation A offering to support expansion in Florida’s dental lab market. The company also reports on investments in equipment and automation, such as upgrades to 3D milling and related lab infrastructure.
More recent releases describe the formal name change from Costas, Inc. to Standard Dental Labs Inc., a reverse stock split, and the shift from the CSSI ticker to CSSID and then to TUTH. Investors and researchers can use this news page to trace how the business focus, regulatory status, and corporate identity evolved over time. For ongoing developments after the symbol transition, users should also review news associated with the updated ticker.
Standard Dental Labs (formerly Costas Inc.) announced FINRA's approval of its name change and ticker symbol transition from 'CSSI' to 'TUTH'. The company will implement a 20:1 reverse stock split effective March 13, 2025, with split-adjusted trading beginning March 14, 2025.
The stock will temporarily trade as 'CSSID' for 20 business days before changing to 'TUTH' around April 10, 2025. The company's outstanding shares will decrease from approximately 572,206,363 to 28,610,318 post-split. The authorized capital remains at 2 billion shares.
All fractional shares will be rounded up, and existing securities (options, warrants, preferred stock, convertible notes) will be adjusted according to the 20:1 ratio. Transfer Online Inc. will manage the exchange process, with stockholders not required to exchange existing certificates.
Standard Dental Labs (OTCMKTS: CSSI) has filed its 2024 Annual Report and Audited Financial Statements for the fiscal year ending December 31, 2024. The company reported:
- Negative revenue growth despite expansion focus
- Ongoing acquisition strategy targeting dental labs in Florida
- Maintained compliance with FINRA and SEC requirements
CEO James Brooks emphasized the company's efforts to strengthen its financial position and expand its footprint through strategic acquisitions and operational efficiencies. The complete annual report and financial statements are accessible through the company's website and OTC Markets disclosure portal.
Standard Dental Labs (OTCMKTS: CSSI) has shared insights on emerging trends in the dental prosthetics industry, highlighting key market shifts toward digital dentistry, automation, and patient-specific customization. The company reported significant investments in 2024, including upgrades to all 3D tooling, state-of-the-art 3D milling equipment, medical-grade compressors, and advanced air filtration systems.
The company is pursuing a measured expansion strategy, focusing on integrating private dental labs in Florida while maintaining quality and service consistency. Their approach emphasizes smart implementation of technology to enhance operational efficiencies without compromising craftsmanship.
Key industry trends identified include:
- Digital Workflows & CAD/CAM Technology adoption
- AI & Automation implementation in case planning and fabrication
- Growing demand for customized, high-quality prosthetic solutions
Standard Dental Labs (OTCMKTS: CSSI) announces two significant developments: near completion of FINRA compliance process and filing of a Tier 2 Regulation A offering. The company has worked with FINRA since March to restore compliance standing, demonstrating commitment to regulatory integrity. The Tier 2 offering, allowing up to $75 million in fundraising over 12 months, aims to address cash flow needs and support expansion in Florida's dental lab market.
CEO James Brooks highlighted these achievements as important milestones following three quarters of addressing operational and financial challenges. The company has collaborated with the SEC, securities counsel, CPAs, and auditors to ensure financial diligence while pursuing its strategy to acquire additional dental laboratories in Florida.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Costas, Inc. (CSSI), operating as Standard Dental Labs, is actively pursuing acquisitions of dental labs in Orlando following its successful acquisition of Prime Dental Lab in August 2022. With an aim to consolidate these facilities into a "Mega Lab," the company has resumed discussions with interested lab owners. Recent communications indicate that five additional lab owners are eager to negotiate with Standard Dental Labs. CEO James Brooks highlights the opportunity presented by retiring baby boomers, stating that many own dental labs. The strategic goal is to grow through acquisitions and expand revenue in the increasingly consolidating dental industry.
ORLANDO, FL / ACCESSWIRE / January 31, 2023 / Costas, Inc. (OTC PINK:CSSI) reflects on 2022 milestones post-CEO James Brooks' appointment. Key achievements include acquiring assets from Standard Dental Labs in March 2022, establishing a focus on acquiring cash-flowing dental labs, and generating its first revenue in 20 years following the Prime Dental Lab acquisition. The dental lab market is valued at $10B in the U.S., and CSSI aims to purchase up to 20 labs in 2023. The company plans to consolidate operations in Orlando, ensuring future revenue growth while emphasizing the need for a strong management team to support its expansion strategy.
FAQ
What is the current stock price of Costas (CSSI)?
